Ma Xin, Ji Xun-Ming, Fu Paul, Ding Yu-Chuan, Xue Qiang, Huang Yue
Department of Neurology, Xuan Wu Hospital, Capital Medical University, Beijing 100053, China.
Chin Med J (Engl). 2015 Jul 5;128(13):1732-7. doi: 10.4103/0366-6999.159345.
Cerebral venous thrombosis (CVT) may lead to serious neurological disorders; however, little is known about the risk factors for recurrent CVT. Our aim was to determine the association between elevated fibrinogen and decreased high-density lipoprotein cholesterol (HDL-C) levels with recurrent CVT.
This retrospective cohort study included participants if they had a first episode of objectively defined CVT and were admitted to Xuan Wu Hospital, Capital Medical University from August 2005 to September 2009. Demographic and clinical variables were collected, as well as laboratory parameters, including plasma fibrinogen and HDL-C. Patients with CVT were followed for recurrent symptomatic CVT. Follow-up was through the end of September 2010. Potential predictors of recurrence were analyzed using Cox survival analysis.
At the end of the follow-up, 95 patients were eligible for the study. Twelve of 95 patients (12.6%) had recurred CVT. The median time of recurrence was 7 months (range: 1-39 months). Eight of these 12 (66.7%) experienced recurrence within the first 12 months after their initial CVT. The recurrence rate of CVT was 2.76 per 100 patient-years. Multivariate Cox regression analysis demonstrated that the coexistence of high fibrinogen (>4.00 g/L) and low HDL-C (<1.08 mmol/L) levels at baseline was the only independent predictor for recurrent CVT (hazard ratio: 4.69; 95% confidence interval: 1.10-20.11; P < 0.05). Of the twelve patients with recurrent CVT in our study, 7 (58.3%) had high fibrinogen plus low HDL-C levels. All 7 of these patients took warfarin for 3-12 months, and 6 of 7 had recurrent CVT after the discontinuation of anticoagulant treatment.
Concomitant high fibrinogen and low HDL-C levels may be associated with recurrence of CVT. The effect of potential risk factors related to atherothrombosis on recurrent CVT should be closely monitored.
脑静脉血栓形成(CVT)可能导致严重的神经功能障碍;然而,关于复发性CVT的危险因素知之甚少。我们的目的是确定纤维蛋白原升高和高密度脂蛋白胆固醇(HDL-C)水平降低与复发性CVT之间的关联。
这项回顾性队列研究纳入了2005年8月至2009年9月期间因首次客观诊断为CVT而入住首都医科大学宣武医院的患者。收集了人口统计学和临床变量,以及实验室参数,包括血浆纤维蛋白原和HDL-C。对CVT患者进行随访,观察是否出现复发性症状性CVT。随访至2010年9月底。使用Cox生存分析来分析复发的潜在预测因素。
随访结束时,95例患者符合研究条件。95例患者中有12例(12.6%)出现了复发性CVT。复发的中位时间为7个月(范围:1 - 39个月)。这12例患者中有8例(66.7%)在首次CVT后的前12个月内复发。CVT的复发率为每100患者年2.76例。多变量Cox回归分析表明,基线时高纤维蛋白原(>4.00 g/L)和低HDL-C(<1.08 mmol/L)水平并存是复发性CVT的唯一独立预测因素(风险比:4.69;95%置信区间:1.10 - 20.11;P < 0.05)。在我们研究的12例复发性CVT患者中,7例(58.3%)同时具有高纤维蛋白原和低HDL-C水平。这7例患者均接受了3 - 12个月的华法林治疗,7例中有6例在抗凝治疗中断后出现了复发性CVT。
纤维蛋白原升高和HDL-C水平降低同时存在可能与CVT复发有关。应密切监测与动脉粥样硬化血栓形成相关的潜在危险因素对复发性CVT的影响。